Global Celiac Disease Market
市场规模（十亿美元）
CAGR :
% 
 Forecast Period |
2022 –2029 |
 Market Size (Base Year) |
USD 720.00 Million |
 Market Size (Forecast Year) |
USD 1,588.86 Million |
 CAGR |
% |
| Major Markets Players |
>全球乳糜泻市场，按治疗方法（英夫利昔单抗、醋酸拉唑肽、无麸质饮食等）、给药途径（口服、肠胃外）、最终用户（医院、家庭护理、其他）、分销渠道（医院药房、网上药房、零售药房）划分 - 行业趋势和预测到 2029 年。
市场分析和见解
乳糜泻是一种自身免疫性疾病，其中一种名为麸质的蛋白质会损害小肠膜。麸质可能存在于黑麦、大麦和小麦等谷物中。麸质会引起免疫反应，损害小肠绒毛（小肠中促进吸收的小指状突起）。这种损害会阻碍人体吸收蛋白质、营养素、脂质、维生素、碳水化合物和矿物质的能力。最终导致营养不良。
Data Bridge Market Research 分析称，2021 年乳糜泻市场价值为 7.2 亿美元，到 2029 年可能达到 15.8886 亿美元，预计在 2022 年至 2029 年的预测期内复合年增长率为 10.40%。Data Bridge Market Research 团队策划的市场报告包括深入的专家分析、患者流行病学、管道分析、定价分析和监管框架。
报告范围和市场细分
|
报告指标 |
细节 |
|
预测期 |
2022 至 2029 年 |
|
基准年 |
2021 |
|
历史岁月 |
2020（可定制至 2019 - 2014） |
|
定量单位 |
收入（百万美元）、销量（单位）、定价（美元） |
|
涵盖的领域 |
治疗（英夫利昔单抗、醋酸拉唑肽、无麸质饮食、其他）、给药途径（口服、肠胃外）、最终用户（医院、家庭护理、其他）、分销渠道（医院药房、网上药房、零售药房） |
|
覆盖国家 |
美国、加拿大、墨西哥、巴西、阿根廷、秘鲁、南美洲其他地区、德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、匈牙利、立陶宛、奥地利、爱尔兰、挪威、波兰、欧洲其他地区、中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、越南、亚太其他地区、沙特阿拉伯、阿联酋、埃及、以色列、科威特、南非、中东和非洲其他地区 |
|
涵盖的市场参与者 |
Innovate Biopharmaceuticals（美国）、Teva Pharmaceutical Industries Ltd（以色列）、ImmunogenX, LLC（美国）、安进（美国）、ChemoCentryx, Inc（美国）、Anokion SA（瑞士）、COUR Pharmaceutical（美国）、F. Hoffmann-La Roche Ltd（瑞士）、BioLineRx Ltd（以色列）和武田药品工业株式会社（日本） |
|
市场机会 |
|
市场定义
Celiac disease, also known as the celiac sprue or gluten-sensitive enteropathy. It is an immune reaction to eating gluten, a protein found in barley, wheat and rye. Eating gluten triggers an immune response in one’s small intestine.
Celiac Disease Market Dynamics
Drivers
Major factors that are expected to boost the growth of the celiac disease market in the forecast period are follows:
- Rise in the incidence of celiac disease population
Due to the growing celiac disease population, there is a rise in the demand in the application of gluten-free products which acts as one of the major factors driving the growth of celiac disease market.
- Increase in the investment in research and development
Robust research and development activities are bringing newer treatment options which is one of the major contributor to the market growth.
- Growing awareness regarding the celiac disease
Rising awareness related to the disease because consumption of gluten is further anticipated to propel to the market growth.
Opportunities
In addition, the growing initiatives by the government will further provide potential opportunities for the growth of the celiac disease market in the coming years.
Restraints/Challenges
On the other hand, the decrease in the number of effective treatment is further projected to impede the growth in the celiac disease market in the timeline period. However, the increased cost involved in research might further challenge the growth of the celiac disease market in the near future.
This celiac disease market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on celiac disease market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Patient Epidemiology Analysis
The celiac disease market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analyses of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.
COVID-19 Impact on Celiac Disease Market
The pandemic of COVID-19 has had a huge impact on the celiac disease market. Lockdowns and isolation during pandemics complicate the disease management and medication adherence. The lack of access to health-care facilities for routine treatment and medication administration will further affect the market. On the other hand, the development of vaccines and renunciation of lockdown has helped the market to advance its growth. Also the market players are investing to improve celiac disease market growth in the forecast period.
Global Celiac Disease Market
The celiac disease market is segmented on the basis of treatment, type, route of administration, end users and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Treatment
- Infliximab
- Larazotide Acetate
- Gluten Free Diet
- Others
On the basis of treatment, the celiac disease market is segmented into infliximab, larazotide acetate, gluten free diet, others.
Route of Administration
- Oral
- Parenteral
On the basis of route of administration, the celiac disease market is segmented into Oral, Parenteral.
End Users
- Hospitals
- homecare
- Others
On the basis of end users, the celiac disease market is segmented into hospitals, homecare, others.
Distribution Channel
- Hospital Pharmacy
- Online Pharmacy
- Retail Pharmacy
On the basis of distribution channel, the celiac disease market is segmented into hospital pharmacy, online pharmacy, retail pharmacy.
Celiac Disease Market Regional Analysis/Insights
The celiac disease market is analysed and market size insights and trends are provided by country, treatment, type, route of administration, end users and distribution channel as referenced above.
The countries covered in the celiac disease market report are the U.S., Canada, Mexico in North America, Brazil, Argentina, Peru, Rest of South America, as part of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, in the Asia-Pacific, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa, as a part of Middle East and Africa.
North America dominates the celiac disease market due to the rise in the refined healthcare expenses. Furthermore, the increase in the patient awareness level growing incidence of celiac diseases will further boost the growth of the celiac disease market in the region during the forecast period.
由于全球市场参与者的出现，预计欧洲乳糜泻市场将出现大幅增长。此外，政府对疫苗开发的支持不断增加，预计将在未来几年进一步推动该地区乳糜泻市场的增长。
报告的国家部分还提供了影响单个市场因素和国内市场法规变化，这些变化影响了市场的当前和未来趋势。新销售、替代销售、国家人口统计、疾病流行病学和进出口关税等数据点是用于预测单个国家市场情景的一些主要指标。此外，在对国家数据进行预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀缺竞争而面临的挑战、销售渠道的影响。
竞争格局和乳糜泻 市场份额分析
乳糜泻市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对乳糜泻市场的关注有关。
乳糜泻市场的一些主要参与者包括：
- Innovate Biopharmaceuticals（美国）
- 梯瓦制药工业有限公司 (以色列)
- ImmunogenX, LLC（美国）
- 安进（美国）
- ChemoCentryx, Inc（美国）
- Anokion SA（瑞士）
- COUR 制药（美国）
- F. Hoffmann-La Roche Ltd（瑞士）
- BioLineRx Ltd（以色列）
- 武田药品工业株式会社 (日本)
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
